Want to see JP:9267 full AI Analyst Report?
9267 Stock Chart & Stats
¥3770.00
-¥35.00(-0.93%)
At close: 4:00 PM EDT
¥3770.00
-¥35.00(-0.93%)
Day’s Range― - ―
52-Week Range¥3,175.00 - ¥5,460.00
Previous CloseN/A
Volume141.40K
Average Volume (3M)62.69K
Market Cap
¥114.82B
Enterprise Value¥133.51K
Total Cash (Recent Filing)¥7.87B
Total Debt (Recent Filing)¥39.64B
Price to Earnings (P/E)14.4
Beta0.46
Next Earnings
Nov 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.35%
Share Statistics
EPS (TTM)258.51
Shares Outstanding31,042,568
10 Day Avg. Volume60,060
30 Day Avg. Volume62,690
Financial Highlights & Ratios
PEG Ratio1.17
Price to Book (P/B)1.68
Price to Sales (P/S)0.47
P/FCF Ratio-32.89
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)287.6
Revenue Forecast (FY)¥243.50B
Bulls Say, Bears Say
Bulls Say
Consistent Revenue GrowthSustained top-line expansion from 155B to 221B over 2022–2026 signals durable demand for Genky’s retail offering and execution in store-level sales. Persistent revenue growth supports capacity to reinvest in the store network and defend market share over the medium term.
Improving Operating Cash FlowMaterial rise in operating cash flow indicates stronger earnings quality and better working-capital management, providing a more reliable internal funding source for capex, inventory and store operations. This improves financial flexibility versus reliance on external financing.
Stronger Leverage And Equity BaseLower leverage and a doubling of equity over several years strengthen the balance sheet, increasing resilience to shocks and capacity for strategic investments or acquisitions. Consistent ROE (~11.7%–15%) shows capital is being deployed effectively, supporting medium-term stability.
Bears Say
Volatile And Often Negative Free Cash FlowFrequent negative free cash flow despite improving operating cash flow points to heavy reinvestment or timing issues, reducing the company’s ability to consistently fund debt repayment, dividends or buybacks from internal cash. This raises funding and liquidity risk over the medium term.
Thin Margins And Gross Margin CompressionLow and narrowing margins limit the company’s buffer against cost inflation or competitive price pressure. Structural gross-margin erosion suggests sourcing, pricing or mix challenges that could compress earnings power and constrain reinvestment or capital returns over the next several quarters.
Rising Absolute Debt In Latest YearAn uptick in absolute debt despite improved ratios implies new borrowings or financing needs. Coupled with volatile FCF, higher nominal debt raises refinancing and interest-exposure risk and makes continued balance-sheet improvement contingent on consistent cash conversion and margin stability.
Genky DrugStores Co., Ltd. News
9267 FAQ
What was Genky DrugStores Co., Ltd.’s price range in the past 12 months?
Genky DrugStores Co., Ltd. lowest stock price was ¥3175.00 and its highest was ¥5460.00 in the past 12 months.
What is Genky DrugStores Co., Ltd.’s market cap?
Genky DrugStores Co., Ltd.’s market cap is ¥114.82B.
When is Genky DrugStores Co., Ltd.’s upcoming earnings report date?
Genky DrugStores Co., Ltd.’s upcoming earnings report date is Nov 02, 2026 which is in 89 days.
How were Genky DrugStores Co., Ltd.’s earnings last quarter?
Genky DrugStores Co., Ltd. released its earnings results on Jul 28, 2026. The company reported ¥73.9 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Genky DrugStores Co., Ltd. overvalued?
According to Wall Street analysts Genky DrugStores Co., Ltd.’s price is currently Overvalued.
Does Genky DrugStores Co., Ltd. pay dividends?
Genky DrugStores Co., Ltd. pays a Semiannually dividend of ¥6.5 which represents an annual dividend yield of 0.35%. See more information on Genky DrugStores Co., Ltd. dividends here
What is Genky DrugStores Co., Ltd.’s EPS estimate?
Genky DrugStores Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Genky DrugStores Co., Ltd. have?
Genky DrugStores Co., Ltd. has 31,042,568 shares outstanding.
What happened to Genky DrugStores Co., Ltd.’s price movement after its last earnings report?
Genky DrugStores Co., Ltd. reported an EPS of ¥73.9 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.163%.
Which hedge fund is a major shareholder of Genky DrugStores Co., Ltd.?
Currently, no hedge funds are holding shares in JP:9267
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Genky DrugStores Co., Ltd.
Genky DrugStores Co., Ltd. engages in the management and operation of food and drug chain stores in Japan. Genky DrugStores Co., Ltd. was founded in 1988 and is headquartered in Sakai, Japan.
Technical Analysis
Sundrug Co
―
Sugi Holdings Co
―
TSURUHA Holdings
―
COSMOS Pharmaceutical Corporation
―
KUSURI NO AOKI HOLDINGS CO.,LTD.
―